Alpine Immune Sciences Inc (ALPN)
65.00
+0.04
(+0.06%)
USD |
NASDAQ |
May 17, 16:00
65.00
0.00 (0.00%)
After-Hours: 20:00
Alpine Immune Sciences Free Cash Flow: -80.96M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -80.96M |
| December 31, 2023 | -79.50M |
| September 30, 2023 | -77.32M |
| June 30, 2023 | -77.92M |
| March 31, 2023 | -75.83M |
| December 31, 2022 | -44.17M |
| September 30, 2022 | -42.04M |
| June 30, 2022 | 4.495M |
| March 31, 2022 | 6.067M |
| December 31, 2021 | -15.37M |
| September 30, 2021 | -10.42M |
| June 30, 2021 | -46.01M |
| March 31, 2021 | 23.02M |
| December 31, 2020 | 29.28M |
| September 30, 2020 | 32.96M |
| June 30, 2020 | 27.70M |
| March 31, 2020 | -34.57M |
| December 31, 2019 | -36.17M |
| September 30, 2019 | -39.42M |
| Date | Value |
|---|---|
| June 30, 2019 | -36.29M |
| March 31, 2019 | -35.71M |
| December 31, 2018 | -28.91M |
| September 30, 2018 | -25.42M |
| June 30, 2018 | -17.46M |
| March 31, 2018 | -13.27M |
| December 31, 2017 | -17.16M |
| September 30, 2017 | -16.44M |
| June 30, 2017 | -24.36M |
| March 31, 2017 | -27.76M |
| December 31, 2016 | -26.36M |
| September 30, 2016 | -26.62M |
| June 30, 2016 | -24.86M |
| March 31, 2016 | -21.49M |
| December 31, 2015 | -19.40M |
| September 30, 2015 | -17.12M |
| June 30, 2015 | -14.46M |
| March 31, 2015 | -14.76M |
| December 31, 2014 | -14.45M |
Free Cash Flow Range, Past 5 Years
-80.96M
Minimum
Mar 2024
32.96M
Maximum
Sep 2020
-28.62M
Average
-36.23M
Median
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals Inc | 3.479B |
| Eliem Therapeutics Inc | -7.241M |
| Regeneron Pharmaceuticals Inc | 3.930B |
| Vera Therapeutics Inc | -99.72M |
| Eyenovia Inc | -29.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.69M |
| Cash from Investing (Quarterly) | -2.562M |
| Cash from Financing (Quarterly) | 19.35M |
| Free Cash Flow Per Share (Quarterly) | -0.4327 |
| Free Cash Flow to Equity (Quarterly) | -27.71M |
| Free Cash Flow Yield | -2.30% |